Title: Prostate SBRT – Heterogeneous Dose Distribution: Rationale, Methods, Outcomes and Future Direction: 2017 Update
Presenter: Donald B. Fuller, MD
Moderator: John J. Kresl, MD, PhD, FACRO, FACR, DABR
Date: Tuesday, July 25, 2017
Time: 1:30 pm ET / 10:30 am PT
Where: Your Computer and/or Telephone
During the presentation Dr. Fuller will present the background and rationale for treating the prostate with SBRT and “HDR-like” SBRT methodology. He will also discuss treatment outcomes including PSA Response, Disease-Free Survival, GU/GI Toxicity and Quality of Life Outcomes using EPIC and SHIM measures. There is also a new section on image-guided “relapse troubleshooting” management for the unfortunate minority of patients who do relapse. To sum up, the lessons learned and future directions will be presented.
Dr. John J. Kresl will be the moderator for this 1-hour session.
Presenter & Moderator
Donald B. Fuller, MD, is Radiation Oncologist with Genesis Healthcare Partners in San Diego, California. His interests in the specialty include prostate cancer radiotherapy, prostate SBRT, and radiation dose escalation for a variety of malignancies through the appropriate application of intensity modulated radiotherapy (IMRT) and stereotactic (SBRT) techniques. He is the national principal investigator of a multi-institutional, prostate CyberKnife clinical trial: PROSPECTIVE EVALUATION OF CYBERKNIFE STEREOTACTIC RADIOSURGERY FOR LOW AND INTERMEDIATE RISK PROSTATE CANCER: EMULATING HDR BRACHYTHERAPY DOSIMETRY, and has also published an original CT-ultrasound fusion prostate brachytherapy technique in peer reviewed literature, as well as original manuscripts in the areas of lung cancer, pediatric cancer, sarcoma and gynecologic oncology.
John J. Kresl, MD, PhD, FACRO, FACR, DABR, is the Medical Director of the Phoenix CyberKnife and Radiation Oncology Center and the Department of Radiation Oncology at Banner Good Samaritan Medical Center – is an internationally recognized expert in stereotactic radiosurgery (SRS) and stereotactic body radiotherapy (SBRT). Dr. Kresl will be the moderator for this 1-hour session.